Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR in dumping syndrome
2005-003250-98Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Oct 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of octreotide in dumping syndrome, sponsored by UZ Leuven. Started Oct 2005; status: completed.
02
Drugs
octreotide
03
Conditions
dumping syndrome
Beyond the preview
Go deeper on 2005-003250-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003250-98.